Enhanced differentiation of fibroblast-like pre-adipocytes into mature adipocytes by the use of compounds mimicking insulin functions or enhancing insulin sensitivity provides a novel strategy for controlling the complications of metabolic syndrome [49–51]. This evidence concerns the gene INS and metabolic syndrome.